Carmen G. O.
- Country
- Spain
- Department
- Neurology Department
Research Overview
- Long-Term Safety and Tolerability of Atogepant for Migraine Prevention in Chronic or Episodic Migraine: A Phase 3, 156-Week Extension Study
- Randomized, Double-Blind, Placebo-Controlled Trial of Galcanezumab in Adolescents Aged 12-17 with Chronic Migraine: REBUILD-2 Study
- Randomized, Double-Blind, Placebo-Controlled Trial of Galcanezumab for Preventive Treatment of Episodic Migraine in Pediatric Patients Aged 6-17 Years
Data & Insights
Has run more than one trial at 182 of 322 partner sites.
Specializations
Neurodegenerative Disease and Movement Disorders
Clinical research activity includes Parkinson’s disease, Alzheimer’s disease, frontotemporal dementia, progressive supranuclear palsy, and multiple system atrophy, with interest in conditions affecting cognition, motor function, and disease progression.
- Parkinson’s disease
- Alzheimer’s disease
- Frontotemporal dementia
- Progressive supranuclear palsy
The therapeutic focus extends to symptom control, neuroprotection, and interventions for fatigue, anhedonia, and other neuropsychiatric features linked to chronic neurological illness.
Neurologic Pain and Epilepsy
Research involvement covers migraine, trigeminal neuralgia, partial-onset seizures, and childhood epilepsy, reflecting a strong therapeutic interest in disorders of pain processing and seizure control.
- Chronic migraine
- Trigeminal neuralgia
- Partial-onset seizures
- Childhood epilepsy
There is also involvement in treatments addressing neuropathic pain and migraine prevention across adult and pediatric populations.
Neuroimmunology and Inflammatory Neurologic Disorders
Clinical interests include multiple sclerosis, myasthenia gravis, amyotrophic lateral sclerosis, and autoimmune disease with neurologic involvement, alongside broader immune-mediated conditions that affect the nervous system.
- Primary progressive multiple sclerosis
- Generalized myasthenia gravis
- Amyotrophic lateral sclerosis
- Autoimmune neurologic disease
Therapeutic work in this area aligns with immune modulation, relapse prevention, and management of disability in chronic inflammatory neurologic disease.
Neuropsychiatric Disorders
The investigator is involved in trials for schizophrenia, treatment-resistant schizophrenia, major depressive disorder, obsessive compulsive disorder, and Tourette syndrome, indicating a broad interest in psychiatric conditions with neurologic overlap.
- Schizophrenia
- Treatment-resistant schizophrenia
- Major depressive disorder
- Tourette syndrome
Research activity in this domain includes therapies targeting mood, cognition, and behavioral symptoms that contribute to functional impairment.
Neurologic Manifestations of Systemic and Rare Disease
Additional clinical involvement spans rare and complex conditions with neurologic expression, including Angelman syndrome, Huntington’s disease, ataxia, and spinal cord injury, reflecting interest in inherited, degenerative, and injury-related neurologic disorders.
- Angelman syndrome
- Huntington’s disease
- Ataxia
- Spinal cord injury
The therapeutic landscape also includes neurologic complications of autoimmune, metabolic, and genetic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.